Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways

Am J Physiol Renal Physiol. 2003 Aug;285(2):F208-18. doi: 10.1152/ajprenal.00311.2002. Epub 2003 Apr 8.

Abstract

We have recently demonstrated the direct involvement of the death receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell (RTC) death. Reactive oxygen species are thought to be a major cause of cellular damage in such injury. The aim of this study was to examine the mechanism through which antioxidants ameliorate cisplatin-induced RTC death, with special emphasis on death receptor-mediated apoptotic pathways. Cisplatin was added to cultures of normal rat kidney (NRK52E) cells or injected in rats. NRK52E cells and rats were also treated with dimethylthiourea (DMTU), a hydroxyl radical scavenger. We then examined the mRNA levels of death ligands and receptors, caspase-8 activity, cell viability, cell death, renal function, and histological alterations. RT-PCR indicated cisplatin-induced upregulation of Fas, Fas ligand, and TNF-alpha mRNAs and complete inhibition by DMTU in vitro and in vivo. Cisplatin increased caspase-8 activity of NRK52E cells, and DMTU prevented such activation. Exposure to cisplatin reduced viability of NRK52E cells, examined by WST-1 assay, and increased apoptosis and necrosis of the cells, examined by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and fluorescence-activated cell sorter analysis. DMTU abrogated cisplatin-induced changes in cell viability and apoptosis and/or necrosis. Cisplatin-induced renal dysfunction and histological damage were also prevented by DMTU. DMTU did not hinder cisplatin incorporation into RTCs. Our results suggest that antioxidants can ameliorate cisplatin-induced acute renal failure through inactivation of the death receptor-mediated apoptotic pathways.

MeSH terms

  • Animals
  • Antigens, CD / genetics
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / toxicity*
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects*
  • Caspase 8
  • Caspase 9
  • Caspases / metabolism
  • Cell Line
  • Cisplatin / pharmacokinetics
  • Cisplatin / toxicity*
  • Fas Ligand Protein
  • Free Radical Scavengers / pharmacology
  • Gene Expression / drug effects
  • In Vitro Techniques
  • Kidney Tubules / drug effects
  • Kidney Tubules / pathology*
  • Kidney Tubules / physiopathology
  • Membrane Glycoproteins / genetics
  • Necrosis
  • RNA, Messenger / analysis
  • Rats
  • Receptors, Tumor Necrosis Factor / genetics
  • Receptors, Tumor Necrosis Factor, Type I
  • Thiourea / analogs & derivatives*
  • Thiourea / pharmacology*
  • Tumor Necrosis Factor-alpha / genetics
  • Up-Regulation
  • fas Receptor / genetics

Substances

  • Antigens, CD
  • Antineoplastic Agents
  • Antioxidants
  • Fas Ligand Protein
  • Faslg protein, rat
  • Free Radical Scavengers
  • Membrane Glycoproteins
  • RNA, Messenger
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • 1,3-dimethylthiourea
  • Casp8 protein, rat
  • Casp9 protein, rat
  • Caspase 8
  • Caspase 9
  • Caspases
  • Thiourea
  • Cisplatin